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The reaction of Na-protected amino/peptide acid with N,O-dimethylhydroxylamine hydrochloride in the
presence of T3P and DBU to obtain enantiomerically pure Na-protected amino/peptidyl Weinreb amides
in high yields has been described. Fmoc-Ala-Weinreb amide 2a is obtained as single crystal, and its
structure was determined through X-ray crystallography.
 2012 Elsevier Ltd. All rights reserved.Weinreb amides1 have been employed as efﬁcient and useful
compounds for the preparation of ketones,2 aldehydes,3 acetylenes,4
heterocycles,5 natural products6 andalso as a proliﬁcmoiety inBirch
reductions andWittig reactions aswell.7,8 RecentlyWeinreb amides
have been utilized in the synthesis of triﬂuoromethylketones.9 A
speciﬁc class is the N-protected amino/peptide Weinreb amides,
which are the key constituents for the preparation of unnatural ami-
no acids and peptidomimetics.10 Classically, these derivatives have
been synthesized by the treatment of N,O-dimethylhydroxylamine
with an activated carboxylic group. Several peptide coupling re-
agents have been employed in this transformation which include
BOP,11 DCC,12 DCC/HOBt,13 CBr4/PPh3,14 EDC/HOBt,15 and CDMT.16
Additionally, mixed anhydride,17 acid chloride,18 acid ﬂuoride19,
and acyl benzotriazole20 methods have also been used under varied
reaction conditions.
Some of these procedures are reported to be efﬁcient, neverthe-
less, several limitations like poor yields, long coupling duration,
harsh conditions, and tedious product isolation have evoked the
search of efﬁcient reagent system. Recently, 1-[(1-cyano-2-eth-
oxy-2oxoethylideneaminooxy)-dimethylaminomorpholinomethyl
ene)]methanaminiumhexaﬂuoro phosphate (COMU)21 was em-
ployed to convert N-Boc-protected amino acids into the corre-
sponding Weinreb amides in good yield and purity. As COMU is
very expensive, it is less attractive for large scale preparations.
The recent demand for efﬁcient and environmentally benign
syntheses of ﬁne chemicals and pharmaceuticals has lead to thell rights reserved.
obile: +91 09986312937.
l.com, hariccb@hotmail.com,development of mild and efﬁcient synthetic reagents. In this re-
spect from past decade the use of T3P (1-propanephosphonic acid
cyclic anhydride) has experienced an exponential growth. The dis-
tinctive environmental beneﬁts of T3P over other conventional re-
agents are due to its less toxicity, mild reaction conditions, broad
functional group tolerance, high yields, less cost, low epimeriza-
tion, and commercial availability. In addition, the formation of
water soluble byproducts makes the isolation of the desired prod-
uct simple and circumvents the use of volatile organic compounds
(VOCs) during work-up. More importantly, T3P22 has experienced a
renaissance as eco-friendly coupling reagent, which has been fre-
quently described as most effective coupling reagent in the ﬁeld
of peptide chemistry.23 The advantages of T3P have been utilized
in organic synthesis not only as coupling reagent but also as dehy-
drating agent and for various functional group interconversions
that is, for the synthesis of nitriles, isonitriles, oxadiazoles, and thi-
adiazoles.24 Recently, T3P has been used as catalyst for the prepa-
ration of polysubstituted quinolines25 and for the synthesis of
fused heterocycles.26 Our group has reported the Curtius27a and
Lossen rearrangements mediated by T3P.27b Also, T3P has been
employed for the synthesis of Na-protected aminothio acids27c
and b- and c-amino alcohols.27d In continuation of our interest
on the utility of T3P, we herein describe the synthesis of enantio-
merically enriched N-protected a-amino/peptide pure Weinreb
amides mediated by T3P under mild conditions and the results
are summarized herein.
A thorough literature survey on the T3P mediated Weinreb
amide preparations revealed that, side chain c-COOH of N-Boc-
Glu-OMe was converted into respective Weinreb amide by the
treatment of T3P and N-ethylmorpholine (NEM). Initially, we
Table 1
Optimization of reaction conditions for the synthesis of 2a
FmocHN N
O
OFmocHN OH
O
 T3P, base
     solvent
a2a1
(MeO)MeNH.HCl
Entrya Base Solvent Yield (%) Time (min)
1 NEM THFb 71c 30
2 DMAP CH3CN — 40
3 Imidazole CH3CN — 40
4 NMM CH3CN 79c 35
5 TEA CH3CN 81c 35
6 Pyridine CH3CN 83c 35
7 DBU CH3CN 97d 30
8 DBU DMSO 75c 40
9 DBU DMF 80d 40
10 DBU THF 69c 35
11 DBU Toluene 71c 40
12 DBU CH2Cl2 78c 35
13 NEM CH3CNc 80c 30
a 1.1 equiv of NHMe(OMe)HCl in 1.1 equiv of TEA was used.
b Reported reaction conditions were maintained.
c Isolated yield after column puriﬁcation.
d Yields of the crude product after work-up followed by triturating with ether.
PgHN
N
R
O
OPgHN
OH
R
O
T3P, DBU
   CH3CN
1a-p 2a-p
(MeO)MeNH.HCl,
0°C, 30 min
Pg = Fmoc, Boc or Cbz group
R = amino acid side chain
Scheme 1. Synthesis of Na-protected amino acid derived Weinreb amides.
Table 2
List of Na-Fmoc/Boc/Cbz-protected amino acid Weinreb amides
Entry Product 2 ½a25D b Yield
a (%)
a FmocHN
N O
O
12.4 97
b
FmocHN N O
O
+18.2 98
c FmocHN N O
O
Ph
18.3 91
d FmocHN N O
O
BocHN
4
15.6 90
e
FmocHN N O
O 25.1 92
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from Fmoc-Ala-OH 1a following this literature protocol.28 The
same reaction conditions failed to give good yield of 2a (Table 1,
entry 1) in 30 min. Consequently, we examined the ability of vari-
ous bases to promote the reaction of 1a with T3P and N,O-dim-
ethylhydroxylamine at 0 C. The reaction progress was monitored
by the TLC. DMAP and imidazole failed to give the expected prod-
uct in 40 min (Table 1, entries 2 and 3). The use of TEA, NMM, and
pyridine (Table 1, entries 4–6) gave satisfactory yields of 2a after
35 min. However, isolation of the pure product required column
puriﬁcation which precludes the choice of base. The amidine type
base DBU has been found to be more effective than traditional ter-
tiary organic bases in several organic reactions.29 Its high basicity
is attributed by the resonance-stabilized cations. Because of the Le-
wis basic properties (non-nucleophillic) DBU has also been used as
efﬁcient catalyst in organic synthesis.29 Recently, we have demon-
strated the efﬁcacy of DBU for the synthesis of ureas.30 To test the
scope of DBU in the present reaction, we carried out the reaction of
1a and N,O-dimethylhydroxylamine at 0 C in the presence of T3P
and DBU (Table 1, entry 7). After 30 min, TLC examination con-
ﬁrmed that the reaction was found to be complete. A simple aque-
ous work-up of the reaction mixture resulted in the isolation of the
product 2a in high yield and purity (>98% conversion as conﬁrmed
by HPLC analysis). Similar study was undertaken to determine if
solvent played a signiﬁcant role in the reaction outcome. It was
found that CH3CN provided best result in terms of yield and purity
to other solvents including THF, DMF, DMSO, toluene, and CH2Cl2
(Table 1, entries 8–12). Additionally, we carried out the reaction
of 1a with T3P and N,O-dimethylhydroxylamine in the presence
of NEM as a base in CH3CN (Table 1, entry 13). Comparison of
the results obtained in entries 1 and 13 suggested that yields were
also inﬂuenced by the solvent and the good yield was obtained in
CH3CN.
Exploring the scope of the optimized reaction conditions, we
further synthesized a series of compounds 2b–p (Scheme 1).31Entry Product 2 ½a25D b Yield
a (%)
i BocHN
N O
O
BnS
19.1 91
j
CbzHN N O
O
ButO
20.2 89
k CbzHN N O
O
28.2 99
l
BocHN COOMe
O
N
O
26.2 91
m
FmocN
O
O
N O
O
38.1 94
(continued on next page)
Table 2 (continued)
Entry Product 2 ½a25D b Yield
a (%) Entry Product 2 ½a25D b Yield
a (%)
f FmocHN
N O
O
HO
14.5 89 n BocN
O
N O 37.116 89
g FmocHN N O
O
MeS
16.7 90 o FmocHN
O
N O — 75
h
BocHN N O
BnOOC
O 13.9 94 p
CbzHN
O
N O
HO
25.6 93
a Isolated yield.
b (c 1, CH2Cl2).
(a) Chiral HPLC  profile of 2a  
Rt = 11.01 min 
(b) Chiral HPLC  profile of 2b  
Rt = 15.50 min 
(c) Chiral HPLC of racemic mixture of 2a and 
2b. Rt = 11.3 and 15.1 min 
(d) RP-HPLC of crude product 2c
      Rt = 16.0 min 
Figure 1. (a) Chiral HPLC proﬁle of 2a. (b) Chiral HPLC proﬁle of 2b. (c) Chiral HPLC of racemic mixture of 2a and 2b. (d) RP-HPLC RP-HPLC of crude product 2c.
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urating with ether. As furnished in Table 2, yields are good in all
cases (89–99%). The method is compatible with commonly used
N-urethane protecting groups, different side chain functionalized
amino acids (Ser, Tyr, Thr, Lys, and Glu) and sterically hindered
amino acids (Ile and Aib) as well. The RP-HPLC32 analysis of crude
2c (>98% purity) revealed the good purity of the products (Fig. 1d).
Further, several N-protected di and tri-peptide derived Weinreb
amides 4a–g were also synthesized (Scheme 2) and have been ob-
tained in good yields (Table 3). The structural assignment of the
Weinreb amides 2 and 4 was made on the basis of 1H, 13C NMR,
and mass spectral data.33
The optical rotational data obtained for all samples showed that
no racemization of the chiral center on the a-carbon atom occurred
during the synthesis. Also, these values are in consistent to the re-
ported ones in the literature. The chiral HPLC34 analysis was carried
out for enantiomeric pair of Fmoc-L-Ala-Weinreb amide 2a andFmoc-D-Ala-Weinreb amide 2b and intentionally prepared D, L mix-
ture. The samples 2a (Fig. 1a) and 2b (Fig. 1b) had single distinct
peak with retention values at Rt 11.01 and 15.50, respectively. Also
an intentionally made equimolar mixture of 2a and 2b showed a
signiﬁcant difference in the retention times between D and L amino
acid derivatives (Fig. 1c, retention times for the racemic amides de-
rived from 2a and 2bwere Rt 11.3 and 15.1 min). These studies con-
ﬁrmed that the present protocol is free from racemization.
During the course of this study Fmoc-Ala-Weinreb amide 2a
(CCDC No. 900995) was obtained as single crystal and the molecu-
lar structure was determined through X-ray crystallography. Two
literature precedents were found on the crystal structure analysis
of amino acid derived Weinreb amides. Zheng et al.,35 reported
the crystal structure of racemic Boc-L-phenylalanyl N-methoxy-
N-methylamide. Thomas Kolter has reported the crystal structure
of aminobutyric acid derived Weinreb amide.36 In the present
study, the crystals of Weinreb amide 2a suitable for X-ray analysis
PgHN
H
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OH
R1
O R2
O
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N
N
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O R2
O
O
3a-g 4a-g
T3P, DBU,
   CH3CN
(MeO)MeNH.HCl,
 50-90 min
Pg = Fmoc/Boc or Cbz group
R1, R2= amino acid side chains
Scheme 2. Synthesis of Na-protected peptidyl Weinreb amides.
Table 3
List of Na-Fmoc/Boc/Cbz-protected amino peptidyl Weinreb amides
Entry Peptidyl Weinreb amide 4 ½a25D (c l, CHCl3) Yield (%) HRMS [M+Na]
+ Obsd/calcd
a Fmoc-Phe-Lue-N(OMe)Me +58.9 88 566.2622/566.2631
b Fmoc-Ala-Phe-N(OMe)Me 116.3 90 524.2145/524.2161
c Boc-Val-Ala-N(OMe)Me +17.8 87 354.2001/354.2005
d Boc-Phe-Leu-N(OMe)Me 97.1 92 444.2459/444.2474
e Cbz-Ala-Ser(OtBu)-N(OMe)Me 22.5 91 432.2107/432.2111
f Cbz-Phe-Lue-Ala-N(OMe)Me 75.13 90 376.2145/376.2236
g Fmoc-Phg-Val-Gly-N(OMe)Me +112.3 95 595.2511/595.2533
Figure 2. ORTEP diagram with 30% probability ellipsoid with atom numbering.
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structure reveals that orthorhombic non-centrosymmetric space
group P212121 with Z = 4. The crystal structure is mainly stabilized
by strong N–H  O bonds along with weak C–H  O bonds. An OR-
TEP diagram depicted in Figure 2 shows the molecular structure,
the asymmetric unit, and intra and intermolecular H-bonding.
The details of the selected bond lengths, bond angles, and torsion
angle values for compound 2a are given in Supplementary data.37
In conclusion a simple and modular procedure has been de-
scribed for the preparation of a series of N-protected a-amino/pep-
tide Weinreb amides by employing combination of T3P and DBU.
The use of mild conditions enables the isolation of the products
without racemization. The Weinreb amide 2a was obtained as sin-
gle crystal and the molecular structure has been conﬁrmed
through X-ray crystallography.
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1H), 5.51 (d, J = 5.2 Hz, 1H), 7.25–7.77 (m, 8H); 13C NMR (75 MHz, CDCl3) d
17.2, 32.0, 43.1, 46.2, 60.6, 66.5, 125.8, 127.1, 127.6, 128.1, 139.5, 140.9, 153.6,
155.8; HRMS: m/z [M+Na]+ calcd for C20H22N2O4: 377.1477; found: 377.1471.
Na-Fmoc-Phe-Leu-N(OMe)Me (4a): White solid (81%); mp 118 C; IR (KBr):
1706, 1665 cm1; 1H NMR (300 MHz, CDCl3) d 0.98 (d, J = 6.9 Hz, 6H), 1.42 (m,
2H), 1.78 (m, 1H), 2.98 (m, 1H), 3.11 (m, 1H), 3.16 (s, 3H), 3.58 (s, 3H), 4.18 (t,
J = 7.5 Hz, 1H), 4.45 (d, J = 12.5, 2H), 4.54 (d, J = 3.9 Hz, 2H), 4.71 (m, 1H), 5.51
(d, J = 5.5 Hz, 1H), 6.11 (s, br, 1H), 7.11–7.59 (m, 13H); 13C NMR (75 MHz,
CDCl3) d 20.8, 21.4, 30.8, 36.3, 39.2, 43.5, 45.9, 53.6, 59.8, 65.1, 120.1, 125.2,
125.8, 127.0, 127.6, 128.2, 128.5, 138.6, 139.8, 140.9, 155.5, 155.9, 170.6;
HRMS: m/z [M+Na]+ calcd for C32H37N3O5: 566.2631; found 566.2622.
Na-Cbz-Val-N(OMe)Me (2k): Isolated as white solid (99%); mp IR (KBr): 1715,
1650 cm1 1H NMR (300 MHz, CDCl3) d 0.99 (d, J = 10.6 Hz, 6H), 2.25 (m, 1H),
3.19 (s, 3H), 3.58 (s, 3H), 4.21 (d, J = 7.9 Hz, 1H), 5.43 (s, 2H), 7.12 (s, 5H); 13C
NMR (75 MHz, CDCl3) d 17.8, 30.2, 32.0, 53.6, 60.1, 64.6, 127.0, 128.1, 128.4,
139.5, 153.4, 155.2; HRMS: m/z [M+Na]+ calcd for C15H22N2O4: 317.1477;
found: 317.1468.
Na-Boc-Asp-(a-OMe)-N(OMe)Me (2l): Isolated as colorless oil (94%); IR (neat):
1722, 1753 cm1; 1H NMR (300 MHz, CDCl3) d 1.32 (s, 9H), 3.21 (s, 3H), 2.61–
2.75 (m, 2H), 3.18 (s, 3H),3.51 (s, 3H), 4.36 (m, 1H), 4.72 (s, br, 1H), 13C NMR
(75 MHz, CDCl3) d 28.3, 28.5, 32.2, 49.4, 50.9, 60.8, 78.4, 155.2, 170.3, 173.4;
HRMS: m/z [M+Na]+ calcd for found C12H22N2NaO6: 313.1478; found:
313.1462.
34. Chiral HPLC particulars: Agilent 1100 series having G1311A VWD at k = 254 nm,
ﬂow 1.0 mL/min, Column: Phenominex made Lux, pore size-5 l, Cellusole-1,
diameter  length = 250  4.6 mm; Method: 80:20 n-hexane-isopropanol in
isocratic mode in 40 min.
35. Zheng, X.; Isaac, O. D.; Miller, D. D.; Charles, R. R. Chirality 2000, 12, 2.
36. Peter, S.; Thomas, M.; Martin, N.; Heike, H.; Thomas, K. Acta Crystallogr. 2002,
58, 1415.
37. CCDC No. 900995 contains the supplementary crystallographic data for
compound 2a. These data can be obtained free of charge from the Cambridge
Crystallographic Data Center via http://www.ccdc.cam.ac.uk/datarequest/cif.
